Scorpius Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SCPX research report →
About the company
Scorpius Holdings, Inc. , through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities.
- CEO
- Jeff A. Wolf
- IPO
- 2013
- Employees
- 90
- HQ
- San Antonio, TX, US
Price Chart
- Market Cap
- $13.63K
- P/E
- -0.00
- P/S
- 0.01
- P/B
- -0.00
- EV/EBITDA
- -0.95
- Div Yield
- 0.00%
- Gross Margin
- -4.09%
- Op Margin
- -893.90%
- Net Margin
- -580.67%
- ROE
- 0.00%
- ROIC
- 2749405.59%
- Revenue
- $6.24M · -10.75%
- Net Income
- $-32,807,843 · 27.44%
- EPS
- $-13.04 · 96.24%
- Op Income
- $-33,600,261
- FCF YoY
- 19.80%
- 52W High
- $0.15
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -5.55
- Avg Volume
- 8.12K
Get TickerSpark's AI analysis on SCPX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 3, 25 | Thuan Tan Sze | other | 0 |
| May 16, 24 | Wolf Jeffrey Alan | other | 2,500,000 |
| May 16, 24 | Wolf Jeffrey Alan | other | 2,500,000 |
Our SCPX coverage
Recent articles, reports, and earnings notes.
No research on SCPX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SCPX report →Similar companies
Peers in the same neighborhood.